EYPT
Price
$8.25
Change
+$0.05 (+0.61%)
Updated
Jun 5 closing price
Capitalization
567.7M
54 days until earnings call
IMCR
Price
$38.42
Change
+$0.40 (+1.05%)
Updated
Jun 6, 12:55 PM (EDT)
Capitalization
1.91B
61 days until earnings call
Interact to see
Advertisement

EYPT vs IMCR

Header iconEYPT vs IMCR Comparison
Open Charts EYPT vs IMCRBanner chart's image
EyePoint Pharmaceuticals
Price$8.25
Change+$0.05 (+0.61%)
Volume$466.72K
Capitalization567.7M
Immunocore Holdings
Price$38.42
Change+$0.40 (+1.05%)
Volume$505
Capitalization1.91B
EYPT vs IMCR Comparison Chart
Loading...
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
EYPT vs. IMCR commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EYPT is a Buy and IMCR is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (EYPT: $8.25 vs. IMCR: $38.02)
Brand notoriety: EYPT and IMCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: EYPT: 59% vs. IMCR: 54%
Market capitalization -- EYPT: $567.7M vs. IMCR: $1.91B
EYPT [@Biotechnology] is valued at $567.7M. IMCR’s [@Biotechnology] market capitalization is $1.91B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

EYPT’s FA Score shows that 1 FA rating(s) are green whileIMCR’s FA Score has 0 green FA rating(s).

  • EYPT’s FA Score: 1 green, 4 red.
  • IMCR’s FA Score: 0 green, 5 red.
According to our system of comparison, EYPT is a better buy in the long-term than IMCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

EYPT’s TA Score shows that 6 TA indicator(s) are bullish while IMCR’s TA Score has 5 bullish TA indicator(s).

  • EYPT’s TA Score: 6 bullish, 4 bearish.
  • IMCR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, EYPT is a better buy in the short-term than IMCR.

Price Growth

EYPT (@Biotechnology) experienced а +14.42% price change this week, while IMCR (@Biotechnology) price change was +8.50% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.36%. For the same industry, the average monthly price growth was +17.11%, and the average quarterly price growth was +3.22%.

Reported Earning Dates

EYPT is expected to report earnings on Jul 30, 2025.

IMCR is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+11.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMCR($1.91B) has a higher market cap than EYPT($568M). IMCR YTD gains are higher at: 28.881 vs. EYPT (10.738). IMCR has higher annual earnings (EBITDA): -97K vs. EYPT (-144.55M). IMCR has more cash in the bank: 837M vs. EYPT (318M). EYPT has less debt than IMCR: EYPT (24.1M) vs IMCR (434M). IMCR has higher revenues than EYPT: IMCR (334M) vs EYPT (56M).
EYPTIMCREYPT / IMCR
Capitalization568M1.91B30%
EBITDA-144.55M-97K149,019%
Gain YTD10.73828.88137%
P/E RatioN/AN/A-
Revenue56M334M17%
Total Cash318M837M38%
Total Debt24.1M434M6%
FUNDAMENTALS RATINGS
EYPT: Fundamental Ratings
EYPT
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
59
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
45
P/E GROWTH RATING
1..100
16
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
EYPTIMCR
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
77%
Momentum
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
76%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
82%
Bullish Trend 1 day ago
76%
Advances
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 5 days ago
76%
Declines
ODDS (%)
Bearish Trend 16 days ago
89%
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
71%
View a ticker or compare two or three
Interact to see
Advertisement
EYPT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RLSMX10.87N/A
N/A
Lazard US Small Cap Equity Select R6
PJFCX37.35N/A
N/A
PGIM Jennison Growth C
PSTAX20.89N/A
N/A
Virtus KAR Capital Growth A
LAVVX15.65N/A
N/A
Lord Abbett Fundamental Equity R6
MSTVX10.62N/A
N/A
Morningstar Alternatives

EYPT and

Correlation & Price change

A.I.dvisor indicates that over the last year, EYPT has been loosely correlated with LYRA. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if EYPT jumps, then LYRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EYPT
1D Price
Change %
EYPT100%
+0.61%
LYRA - EYPT
58%
Loosely correlated
+9.07%
OCUL - EYPT
56%
Loosely correlated
+0.95%
ATHE - EYPT
54%
Loosely correlated
+5.03%
BEAM - EYPT
54%
Loosely correlated
-0.87%
RXRX - EYPT
53%
Loosely correlated
-7.13%
More